The International Conference On Women Health and Breast Cancer Conference 2025, taking place in the vibrant city of Dubai on November 27-28, will serve as a global hub for dialogue, discovery, and innovation in women's health. This two-day event brings together leading healthcare professionals, researchers, policymakers, and advocates committed to enhancing the well-being of women across all stages of life.
Guided by the theme "Empowering Women's Wellness across the Lifespan," the conference will explore cutting-edge topics such as reproductive and hormonal health, chronic disease prevention, mental wellness, maternal care, and the integration of digital technologies into personalized care. Attendees will engage in keynote presentations, expert panels, interactive sessions, and collaborative workshops designed to inspire action and advance global health equity for women.
Whether you're a clinician, scientist, public health professional, or advocate, this conference offers a unique opportunity to be part of the movement shaping the future of women's healthcare worldwide.
This track explores transformative advancements in reproductive and sexual healthcare aimed at enhancing autonomy, access, and outcomes. Topics include cutting-edge contraceptive technologies, digital health tools for fertility and cycle tracking, and modern STI prevention strategies. It also emphasizes inclusive sexual education, innovations in telehealth for sexual wellness, and equity in reproductive services for diverse populations. The session aims to highlight how innovation can drive empowerment and accessibility in reproductive choices.
Focusing on the hormonal transitions throughout a woman's life, this track addresses the challenges and opportunities surrounding menopause, perimenopause, and aging-related hormonal shifts. Key topics include hormone replacement therapy (HRT), the impact of declining estrogen on bone, brain, and cardiovascular health, and non-hormonal options for symptom relief. Participants will explore how nutrition, exercise, and mental health care can support graceful aging, while also addressing the societal stigmas and knowledge gaps surrounding menopause and older women's health.
Centered on women living with advanced-stage breast cancer, this track provides updates on treatment advancements, clinical trials, and strategies for long-term management. It delves into targeted therapies, personalized medicine, and overcoming resistance to treatment. In addition to clinical care, the track addresses survivorship, emotional health, and the importance of palliative and supportive services to enhance life quality. It also provides space for patient advocacy and strategies to navigate care with dignity and strength.
This track explores how lifestyle choices influence hormonal balance, disease prevention, and overall metabolic health in women. Topics include gender-specific nutritional requirements, the impact of physical activity on insulin sensitivity and inflammation, and holistic approaches to managing PCOS, obesity, and metabolic syndrome. It also emphasizes the role of gut health, mindful eating, and functional fitness in preventing chronic illnesses and promoting long-term wellness across the lifespan.
This track explores the intersection of reproductive technology, policy, and personal autonomy, shedding light on infertility and assisted reproductive technologies (ART). Topics include innovations in IVF, egg and embryo freezing, fertility preservation in cancer patients, and ethical considerations in ART access. The session also discusses reproductive rights, legal barriers, and health disparities affecting who can access fertility care. It advocates for equitable, informed, and compassionate fertility treatment options for all individuals.
This track offers a comprehensive overview of cancer care specific to women, including breast, ovarian, cervical, uterine, and vulvar cancers. It features innovations in early detection, surgical and chemotherapeutic treatments, and genetic counseling for hereditary cancer risk. Attendees will learn about personalized treatment approaches and survivorship programs that consider not just clinical outcomes, but also quality of life, fertility preservation, and long-term monitoring of cancer survivors.
This track promotes a whole-body, patient-centered approach to women's wellness by integrating conventional medicine with complementary therapies. Areas of focus include mind-body techniques like yoga, meditation, and acupuncture, as well as the use of herbal supplements, lifestyle medicine, and nutrition in clinical care. Participants will explore the role of integrative health in managing chronic pain, hormonal imbalances, stress-related conditions, and mental health, ultimately supporting individualized and sustainable wellness solutions.
Addressing a global public health crisis, this track focuses on the profound impact of domestic violence, sexual assault, and gender-based abuse on women's physical and mental health. It covers trauma-informed care models, healthcare provider training, and strategies for screening and early intervention. The session also examines policy frameworks, support networks, and community responses aimed at prevention and survivor empowerment. Central to the discussion is the need for coordinated action across sectors to ensure safety and justice.
This track investigates the relationship between hormonal function and breast cancer development, progression, and treatment. It covers the biology of hormone receptor-positive cancers, the role of estrogen and progesterone, and the impact of hormonal therapies like tamoxifen and aromatase inhibitors. Attention is given to side effect management, resistance to endocrine therapies, and long-term follow-up for hormone-sensitive tumors. The track emphasizes personalized hormonal risk assessment and decision-making in therapy planning.
This track explores the systemic and structural inequities that contribute to poorer health outcomes among marginalized women, including those from racial and ethnic minorities, low-income backgrounds, and rural communities. Topics include disparities in maternal mortality, access to cancer screenings, chronic disease management, and the influence of social determinants of health. The session also highlights culturally competent care models, grassroots advocacy, and research efforts aimed at closing the gap in women's healthcare equity.
Focusing on the external threats to women's well-being, this track examines the impact of environmental toxins and workplace exposures on reproductive, endocrine, and long-term health. Topics include endocrine-disrupting chemicals, air and water pollution, occupational risks in healthcare and industry, and climate change's effect on health outcomes. Policy advocacy, regulatory efforts, and prevention strategies are emphasized to protect women in their homes, workplaces, and communities.
This track focuses on creating inclusive, affirming healthcare spaces for transgender, nonbinary, and LGBTQ+ individuals within women’s health. Discussions include gender-affirming care, inclusive reproductive health services, mental health challenges, and navigating systemic barriers to care. It highlights the need for training, policy change, and community collaboration to ensure safe, respectful, and competent healthcare that meets the diverse needs of all individuals, regardless of gender identity or sexual orientation.
Menstrual health is a key indicator of overall well-being, and this track tackles both the biological and social dimensions of menstruation. Topics include access to affordable and sustainable menstrual products, innovations in period technology, and the global fight against period poverty. It also highlights educational initiatives, policy changes, and community advocacy efforts aimed at reducing stigma and promoting menstrual equity in schools, workplaces, and public life.
This track covers the complex field of high-risk pregnancy and maternal-fetal medicine, focusing on innovations in prenatal care, diagnostics, and treatment for both mother and baby. Topics include gestational hypertension, diabetes, preeclampsia, fetal abnormalities, and preterm birth prevention. Multidisciplinary approaches are emphasized, bringing together obstetricians, geneticists, neonatologists, and midwives to improve maternal and fetal outcomes, especially in vulnerable and underserved populations.
Globalmeetx conferences are crafted to inspire, inform, and connect individuals across sectors. Here's who will benefit the most:
Globalmeetx conferences are more than just events they're growth experiences. Here's why you shouldn't miss out:
Registering for a conference is your gateway to exclusive opportunities that foster growth, connection, and insight. It's more than just attending an event it's a step toward expanding your knowledge, engaging with innovation, and accelerating both personal and professional success.
The women's health market, particularly breast cancer care, is a substantial and growing industry. The global breast cancer market is projected to reach USD 89.01 billion by 2034, growing at a CAGR of 9.90% from 2024 to 2034, according to Precedence Research. This growth is driven by factors like the increasing prevalence of breast cancer, rising awareness about early detection, and advancements in screening and treatment technologies.
Key Market Trends and Drivers:
Rising Prevalence of Breast Cancer:
Breast cancer is the most common cancer in women, impacting millions globally. This high prevalence drives demand for diagnostic tools, treatments, and screening programs.
Increased Awareness and Early Detection:
Growing awareness about the importance of early detection through screening programs like mammography is leading to more women getting screened, which in turn boosts demand for diagnostic devices and services.
Technological Advancements:
Innovations in breast cancer screening and treatment, such as digital mammography, 3D imaging, and targeted therapies, are enhancing accuracy, effectiveness, and patient outcomes, driving market growth.
Focus on Personalized Medicine:
Advances in genomics and targeted therapies allow for more personalized treatment plans based on the specific characteristics of each individual's cancer, leading to more effective treatments and improved patient outcomes.
Growing Healthcare Spending:
Increasing healthcare spending, particularly in developed regions, is contributing to the growth of the breast cancer market, as it allows for better access to advanced treatments and diagnostic technologies.
Growing Asia Pacific Market:
The Asia Pacific region is expected to be a major driver of growth in the women's health market, including breast cancer care, due to demographic trends, increasing healthcare needs, and rising awareness.
Economic Burden:
The economic burden of breast cancer is also on the rise, with estimates suggesting a significant increase in healthcare costs associated with diagnosis, treatment, and care.
Market Segments and Opportunities:
Breast Cancer Screening:
The global breast cancer screening market is experiencing significant growth, driven by the increasing prevalence of breast cancer and the growing adoption of advanced screening technologies like digital mammography and 3D imaging.
Breast Cancer Diagnostics:
Advancements in diagnostic technologies, such as liquid biopsies and genetic testing, are leading to more accurate and timely diagnoses, further fueling market growth.
Breast Cancer Therapeutics:
The development of new and more effective treatments, including targeted therapies and immunotherapies, is driving growth in the breast cancer therapeutics market.
Women's Health Diagnostics Market:
The women's health diagnostics market is experiencing strong growth, driven by increasing awareness of women-specific health issues, technological advancements, and growing healthcare investments.
Hospitals and Clinics:
Hospitals and clinics play a crucial role in the diagnosis and treatment of breast cancer and other women's health conditions, and they are expected to continue to be a major focus for market growth.
Home Healthcare:
The home healthcare segment is expected to grow at a high rate, driven by the increased use of women's health devices and treatments in the home setting.
India Women's Health Therapeutics Market:
The India women's health therapeutics market is also experiencing significant growth, with a projected CAGR of 15.2% during the forecast period.